Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 18, 1996

View Archived Issues

Beta-blocker treatment reduces fatal post-surgical heart attack

Novel GABA uptake inhibitors from Novo Nordisk

Dainippon describes agents that act selectively on peripheral benzodiazepine receptors

Antiangiogenic compounds described by Taiho

Sandoz reports on tetraline derivatives for neurological disorders

Mercian discloses novel antitumor anthracycline antibiotics

Carbapenem esters revealed by SKB

Company Profile: Arris

Company Profile: Bone Care International

ML-3000 progresses through the pipeline

Piliel enters pivotal trials in Europe

Pamidronate effective against skeletal complications in breast cancer patients

Troglitazone hypotensive, hypoglycemic activities established in preclinical model

Corvas and Schering-Plough expand antithrombotic collaboration

Positive results reported for group A Streptococcus vaccine

Beacon obtains rights to Centocor tumor markers

Biovail grants another license for diltiazem product

New alopecia Rx tested in patients

Anti-L-selectin aptamers demonstrate efficacy in animals

Molecular Biosystems and Mallinckrodt expand contrast agent agreement

Shaman and Ono expand diabetes collaboration

GLA effective in treating active rheumatoid arthritis

Sankyo product pipeline in review

Chemopreventive effects of Targretin in breast cancer

Ciba/Sandoz merger approved

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...